Hunan Creator Information Technologies
300730
Shandong Rike Chemical
300214
Jiangsu LiXing General Steel Ball
300421
4
Jiangsu Boiln Plastics
301003
5
Ningbo Henghe Precision Industry
300539
US Stock MarketDetailed Quotes
NRSN NeuroSense Therapeutics
- 1.070
- -0.015-1.36%
Close Feb 25 16:00 ET
- 1.079
- +0.009+0.87%
Post 19:15 ET
24.85MMarket Cap-1.41P/E (TTM)
1.110High1.024Low93.19KVolume1.100Open1.085Pre Close98.80KTurnover0.82%Turnover RatioLossP/E (Static)23.23MShares2.29052wk High-8.84P/B12.16MFloat Cap0.51252wk Low--Dividend TTM11.37MShs Float8.180Historical High--Div YieldTTM7.92%Amplitude0.400Historical Low1.060Avg Price1Lot Size
NeuroSense Therapeutics News
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 20-F: FY2023 Annual Report
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 20-F: FY2022 Annual Report
NeuroSense Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
NeuroSense Therapeutics | 20-F: Registration statement / Annual report / Transition report
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025